Ponatinib
Also known as: AP24534
Panatinib is an anticancer drug. In December 2012, it was approved by FDA to be used in the treatment of adult chronic myeloid leukemia (CML) and Philadelphia chromosome positive (Ph + acute lymphoblastic leukemia (all). It is mainly used to treat patients who have no effect on dasatinib or nilotinib treatment, or who cannot tolerate dasatinib or nilotinib, and patients who are not suitable for follow-up treatment of imatinib. It can also be used to treat patients with gene mutation ("T315I mutation"), which makes patients resistant to imatinib, dasatinib or nilotinib. It is also used to treat CML and Ph + all in adults who have not used other TKIs. At present, it is the only available drug for BCR ABL kinase T315I mutation.
| Payment & Shipping Terms | Supply Capacity | ||
|---|---|---|---|
| Payment Terms: | T/T, WU | Production Capacity: | 1000kg/year |
| Min. Order: | 1 Gram | Packing: | according to the customer's requirements |
| Means of Transport: | Ocean, Air, Land | Delivery Date: | 7 days |
Ponatinib
CAS 943319-70-8
Panatinib is an anticancer drug. In December 2012, it was approved by FDA to be used in the treatment of adult chronic myeloid leukemia (CML) and Philadelphia chromosome positive (Ph + acute lymphoblastic leukemia (all). It is mainly used to treat patients who have no effect on dasatinib or nilotinib treatment, or who cannot tolerate dasatinib or nilotinib, and patients who are not suitable for follow-up treatment of imatinib. It can also be used to treat patients with gene mutation ("T315I mutation"), which makes patients resistant to imatinib, dasatinib or nilotinib. It is also used to treat CML and Ph + all in adults who have not used other TKIs. At present, it is the only available drug for BCR ABL kinase T315I mutation.
We can customize according to customer's requirement
if you have any question pls mail us or call us.
| CAS Number | 943319-70-8 |
|---|---|
| Molecular Formula | C29H27F3N6O |
| Molecular Weight | 532.56 |
| Appearance | white powder |
| lace of Origin | Sichuan,China (Mainland) |
| Brand | MOSINTER |
| Content | 99% |
Send an inquiry for Ponatinib
Related products
1-Bromo-3-chloro-2-methylpropane
Application:Used as pharmaceutical intermediates
1-benzyl-2-phenyl-1H-imidazole
Contact MOSINTER for product specifications and supply information.
10-Hydroxycamptothecin
Exemestane is an irreversible steroidal aromatase inhibitors, has similar structure with its substrate,natural androstenedione. And it is the pseudo substrate of aromatase . The inhibition of aromatase to estrogen deprivation is a effective method in the treatment of postmenopausal women with hormone dependent breast cancer.
2-Chlorophenothiazine
Application:Chlorpromazine hydrochloride used as drug intermediates; Pharmaceutical intermediates for the preparation of chlorpromazine, perphenazine.
3-Dimethylamino-2-methylpropyl Chloride Hydrochloride
Application:Used as pharmaceutical intermediates
3-Dimethylaminopropylchloride Hydrochloride
1. Used for synthesis of chlorpromazine, doxepin hydrochloride, chlorprothixene medicine, etc
3-Ethyl-4-methyl-3-pyrrolin-2-one
3-Ethyl-4-methyl-3-pyrrolin-2-one, a five-membered α,β-unsaturated lactam derivative, has various applications in medicinal chemistry. It can be synthesized by employing following as starting materials:[1] • allylamine, via palladium(II)-assisted cyclization • 4-methoxybenzylamine, via a ring-closing-metathesis strategy • 3-ethyl-1-(4-methoxybenzyl)-4-methyl-1,5-dihydro-2H-pyrrol-2- one
5- 1-Hydroxyl-1-methylethyl -2-propyl-imidazol-4-yl Carboxylic Acid Ethyl Ester
[5-(1-Hydroxyl-1-methylethyl)-2-propyl-imidazol-4-yl]carboxylic acid ethyl ester
